Medicare Enrolled

Dr. Mani Bashyam, M.D.

Endocrinology · Greensburg, PA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
540 SOUTH ST, Greensburg, PA 15601
7248323130
In practice since 2006 (19 years)
NPI: 1801993514 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Bashyam from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bashyam? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Bashyam

Dr. Mani Bashyam is an endocrinology specialist in Greensburg, PA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Bashyam performed 1,084 Medicare services across 715 unique beneficiaries.

Between the years covered by Open Payments, Dr. Bashyam received a total of $13,586 from 63 pharmaceutical and/or device companies across 873 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Bashyam is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 29% volume in PA $13,586 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,084
Medicare services
Top 29% in PA for endocrinology
715
Unique beneficiaries
$68
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~57 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
400 $87 $238
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
221 $8 $17
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
132 $26 $127
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
97 $60 $186
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
81 $117 $310
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
61 $100 $352
New patient office visit, complex (60-74 min) 54 $162 $409
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
26 $60 $168
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
12 $132 $335
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$13,586
Total received (2018-2024)
Avg $1,941/year across 7 years
Top 19% in PA for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
63
Companies
873
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,586 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,803
2023
$1,591
2022
$1,447
2021
$972
2020
$753
2019
$3,500
2018
$3,520

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$305
Dexcom, Inc.
$197
Axonics, Inc.
$191
Radius Health, Inc.
$151
Lilly USA, LLC
$142
SANOFI-AVENTIS U.S. LLC
$137
BETA BIONICS, INC.
$98
Novo Nordisk Inc
$80
Insulet Corporation
$80
Amneal Pharmaceuticals LLC
$77
Corcept Therapeutics
$55
Amphastar Pharmaceuticals, Inc.
$54
Tandem Diabetes Care, Inc.
$50
Abbott Laboratories
$33
Neurocrine Biosciences, Inc.
$30
Alexion Pharmaceuticals, Inc.
$25
Kyowa Kirin, Inc.
$23
Medtronic, Inc.
$23
Xeris Pharmaceuticals, Inc.
$19
ABBVIE INC.
$18
Antares Pharma, Inc.
$15
Top 3 companies account for 38.4% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$1,563
Lilly USA, LLC
$1,475
AstraZeneca Pharmaceuticals LP
$1,086
SANOFI-AVENTIS U.S. LLC
$931
Amgen Inc.
$683
Boehringer Ingelheim Pharmaceuticals, Inc.
$406
Valeritas, Inc.
$403
Dexcom, Inc.
$388
Xeris Pharmaceuticals, Inc.
$378
Bayer HealthCare Pharmaceuticals Inc.
$374
Merck Sharp & Dohme Corporation
$353
Becton, Dickinson and Company
$334
Corcept Therapeutics
$333
Abbott Laboratories
$299
AbbVie, Inc.
$297
Medtronic MiniMed, Inc.
$294
Insulet Corporation
$272
Janssen Pharmaceuticals, Inc
$270
Radius Health, Inc.
$263
Amneal Pharmaceuticals LLC
$210
Tandem Diabetes Care, Inc.
$208
Mannkind Corporation
$206
Antares Pharma, Inc.
$204
MannKind Corporation
$196
Axonics, Inc.
$191
Horizon Therapeutics plc
$145
Medtronic, Inc.
$142
Shire North American Group Inc
$138
Alexion Pharmaceuticals, Inc.
$107
BETA BIONICS, INC.
$98
Amarin Pharma Inc.
$94
PFIZER INC.
$82
VIVUS, Inc.
$76
Aytu BioScience, Inc
$76
DEXCOM, INC.
$73
Ipsen Biopharmaceuticals, Inc
$70
Intuity Medical Inc
$67
RECORDATI_RARE_DISEASES_INC.
$61
AbbVie Inc.
$58
Zealand Pharma US, Inc.
$55
Amphastar Pharmaceuticals, Inc.
$54
VistaPharm, Inc.
$53
Ferring Pharmaceuticals Inc.
$42
Nalpropion Pharmaceuticals LLC
$41
Orexigen Therapeutics, Inc.
$39
Gemini Laboratories, LLC
$35
Merck Sharp & Dohme LLC
$35
Tolmar, Inc.
$34
Bayer Healthcare Pharmaceuticals Inc.
$31
Neurocrine Biosciences, Inc.
$30
LifeScan, Inc.
$29
Genentech USA, Inc.
$24
Kyowa Kirin, Inc.
$23
Endo Pharmaceuticals Inc.
$19
ABBVIE INC.
$18
Companion Medical, Inc.
$17
Supernus Pharmaceuticals, Inc.
$17
Ascensia Diabetes Care Us Inc.
$17
Nalpropion Pharmaceuticals, Inc.
$16
Althera Pharmaceuticals LLC
$15
Eisai Inc.
$14
SANOFI PASTEUR INC.
$14
CeQur Corporation
$12
Top 3 companies account for 30.4% of all-time payments
Associated products mentioned in payments ›
AFREZZA · Androgel · Axonics · BAQSIMI · BD NANO · BD Nano · CONTRAVE · CeQur Simplicity · Crysvita · DEXCOM CGM · DEXCOM G6 TRANSMITTER · Dexcom G6 Transmitter · EVENITY · FARXIGA · FLUZONE HIGH-DOSE · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE HYPOPEN · GVOKE PFS · Guardian Connect · HUMALOG · HUMULIN · HUMULIN U · INPEN SMART INSULIN DELIVERY SYSTEM · INVOKANA · InPen · JANUVIA · JARDIANCE · JATENZO · Kerendia · Korlym · LANTUS · LYRICA · Lenvima · MINIMED 780G · MOUNJARO · MiniMed Connect · Minimed 530G · Minimed 670G System · Minimed 770G System · NATPARA · NATPARA (PARATHYROID HORMONE) · NOCDURNA · Natesto · Omnipod · OneTouch · Otrexup · Ozempic · Pogo Automatic Blood Glucose Monitoring System · Prolia · QSYMIA · RYBELSUS · Repatha · Roszet · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMATULINE DEPOT · SOMAVERT · STEGLUJAN · STRENSIQ · SYNTHROID · Saxenda · Strensiq · Synthroid · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Thyquidity · Tresiba · Tymlos · UNITHROID · V-GO · V-GO DISPOSABLE INSULIN DELIVERY · Vascepa · Victoza · XARELTO · XIAFLEX · XYOSTED · Xofluza · Xultophy 100/3.6 · ZEGALOGUE · ZEPBOUND · ZOMACTON · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an endocrinology specialist in Greensburg?
Compare endocrinologists in the Greensburg area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
48
Per 100K population
13.6
County median income
$72,468
Nearest hospital
EXCELA HEALTH WESTMORELAND REGIONAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Bashyam is a clinical cardiology specialist, with above-average Medicare volume (top 29% in PA), with low-engagement industry engagement in the top 19% of PA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Bashyam experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Bashyam performed 400 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bashyam receive payments from pharmaceutical companies?
Yes. Dr. Bashyam received a total of $13,586 from 63 companies across 873 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bashyam's costs compare to other endocrinologists in Greensburg?
Dr. Bashyam's average Medicare payment per service is $68. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bashyam) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →